Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106676140A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction for clopidogrel intermediates.
Novel enzymatic route for amino alcohol intermediates reduces waste and improves chirality. Reliable supply chain partner for scalable pharmaceutical manufacturing.
Patent CN115927500A details a novel enzymatic route for scopoletin using ferulic acid. Discover cost-effective, scalable biocatalysis for pharmaceutical supply chains.
Novel lipase Ndbn enables green aromatic amide synthesis with enhanced stability. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN114574454B details enzymatic synthesis for Tenofovir intermediates. Discover cost-effective, scalable biocatalytic solutions for pharmaceutical manufacturing.
Patent CN104152505A details enzymatic production of 4-HIL. Offers high yield and scalable supply chain solutions for diabetes treatment intermediates.
Patent CN115466756A discloses novel immobilized transaminases for sitagliptin production. Achieve high conversion, stability, and cost reduction in pharmaceutical manufacturing.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN106795542B details (R)-selective cupin enzymes for chiral beta-nitroalcohol synthesis, offering high purity and cost reduction in API manufacturing.
Patent CN108424937A reveals a novel enzymatic route for Danshensu. Discover cost-effective, scalable production methods for high-purity pharmaceutical intermediates supply.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN121022786A reveals a novel AmDH enzyme for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel whole-cell catalytic method for 2'-fluoro-2'-deoxyadenosine. Reduces purification steps and enhances supply chain reliability for nucleic acid drug manufacturing.
Patent CN119698468A details engineered transaminases for niraparib synthesis, offering high stereoselectivity and scalable biocatalytic solutions for pharmaceutical supply chains.
Patent CN111172124B details a YOL151W mutant for high-concentration synthesis, offering cost-effective pharma intermediate manufacturing.
Novel dual-enzyme mutant catalyst enhances (S)-Bosone production efficiency. Reduces cofactor costs and improves supply chain reliability for cosmetic manufacturers.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Novel Gibberella intermedia method for steroid intermediates. High yield conversion reduces manufacturing costs and ensures supply chain reliability for pharmaceutical partners globally.
Patent CN103555683B reveals high-purity saxagliptin intermediate synthesis via PDH mutant. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101284797A details enzymatic resolution of N-protected allylglycinate using subtilisin crystals for high purity chiral intermediates.